Promoter methylation of each of these genes occurred in approximately 30% of bladder cancers, and both RASSF1A and PRSS3 promoter methylation were associated with advanced tumor stage (P&lt;0.001 and P&lt;0.04, respectively).
C0005684
Malignant neoplasm of urinary bladder